Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
26.33 EUR
0.34%
Market Closed
Updated:
Apr 20, 2024
Bayer AG
Interest Income Expense
Last
Value
3-Years CAGR
5-Years CAGR
|
Bayer AG
Interest Income Expense Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Interest Income Expense
€-852m
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-2%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Interest Income Expense
$-1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Interest Income Expense
€-42m
|
CAGR 3-Years
51%
|
CAGR 5-Years
31%
|
CAGR 10-Years
14%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Interest Income Expense
€30.4m
|
CAGR 3-Years
37%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Interest Income Expense
€-75m
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-87%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Interest Income Expense
€-1.9m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-148%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Interest Income Expense?
Interest Income Expense
-852m
EUR
-852m
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Interest Income Expense amounts to -852m EUR.
What is Bayer AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-2%
-2%
Over the last year, the Interest Income Expense growth was 62%. The average annual Interest Income Expense growth rates for Bayer AG have been 3% over the past three years , 7% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
